Eidt-Koch Daniela, Wagner Thomas O F, Mittendorf Thomas, Reimann Andreas, von der Schulenburg J-Matthias
Faculty of Public Health Services, Ostfalia, University of Applied Services, Wolfsburg, Germany.
Pediatr Pulmonol. 2011 Mar;46(3):278-85. doi: 10.1002/ppul.21364. Epub 2010 Nov 17.
Objective of this study is to assess and evaluate resource use in outpatient treatment in Germany and to compare it with remuneration.
Outpatient treatment was evaluated in seven different centers for pediatric and adult CF patients. Data were recorded during one representative month in 2006. A micro-costing approach was used to value resource use data.
For outpatient treatment mean costs (excluding drugs) of 488 € per patient per quarter occurred. Correlation analyses identified significant cost drivers including age and co-morbidities (pancreatic insufficiency, hepatobiliary complications, lung function capacity, or bacterial lung colonization). Remuneration covered only 51% of the total costs (252 € per patient/quarter).
As the human resources available to these centers today are already below the requirements set by the European consensus for standards of CF care it will be important for a high level of patient care to reach a cost-covering remuneration scheme.
本研究的目的是评估和评价德国门诊治疗中的资源使用情况，并将其与薪酬进行比较。
在七个不同的中心对儿科和成人囊性纤维化（CF）患者的门诊治疗进行了评估。数据记录于2006年一个具有代表性的月份。采用微观成本核算方法对资源使用数据进行估值。
门诊治疗中，每位患者每季度的平均成本（不包括药物）为488欧元。相关分析确定了包括年龄和合并症（胰腺功能不全、肝胆并发症、肺功能、或肺部细菌定植）在内的显著成本驱动因素。薪酬仅覆盖总成本的51%（每位患者/每季度252欧元）。
由于目前这些中心可用的人力资源已经低于欧洲CF护理标准共识所设定的要求，因此实现成本覆盖的薪酬方案对于高水平的患者护理至关重要。
